Evening Primrose Oil 500 mg By American Health Royal Brittany Overview & Drug Interactions

Check For Interactions With Evening Primrose Oil 500 mg

Supplement: Evening Primrose Oil 500 mg by American Health Royal Brittany

Evening Primrose Oil 500 mg Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Evening Primrose Oil 500 mg by American Health Royal Brittany

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Softgel(s)
Maximum serving Sizes:
1 Softgel(s)
UPC/BARCODE 076630036320

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Calories
5 {Calories}
Header
Calories from Fat
5 {Calories}
Header
Total Fat
0.5 Gram(s)
Fat (unspecified) 1%
Evening Primrose Oil
500 mg
Evening Primrose oil --
Linoleic Acid
365 mg
Linoleic Acid --
Gamma-Linolenic Acid
45 mg
Gamma Linolenic Acid --

Other Ingredients:
Gelatin
Vegetable Glycerin


Label Statments:


General
- Prod. No. 73632 B3631 09B
Formulation
- No gluten, no yeast, no wheat, no milk or milk derivatives, no lactose, no soy, no egg, no corn, no grapefruit, no sugar, no starch, no preservatives, no artificial color, no artificial flavor, no sodium. 100% pure solvent free
- The EPO used for Royal Brittany is 100% natural, cold pressed and is void of hexane and all other solvent residue.
- Hexane free 100% certified Solvent free
General Statements
- The consistency of potency is guaranteed by assay.
- For centuries, women have depended on the reliability of evening primrose oil.
- Buy 1 get 1 free Free bottle enclosed
- Part No. 22-36329
Precautions
- Warning: If you are pregnant, nursing, taking any medications, planning any medical or surgical procedure or have any medical condition, consult your doctor before use.
- Discontinue use and consult your doctor if any adverse reactions occur.
- Keep out of reach of children.
- Do not use if seal under cap is broken or missing.
Storage
- Store at room temperature.
FDA Disclaimer Statement
- This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
- These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
Seals/Symbols
- Laboratory tested Guaranteed quality
Formula
- Helps promote women's health
- 500 mg 45 mg GLA (9%)
- EPO contains one of the richest sources of Gamma-Linolenic Acid (GLA - 45 mg per serving), a fatty acid not commonly found in food.
- Popular with women of all ages, EPO is traditionally used to provide nutritional support for women with PMS.
FDA Statement of Identity
- Dietary Supplement
Suggested/Recommended/Usage/Directions
- Directions: For adults, take one (1) softgel six times daily, preferably with meals.
Brand IP Statement(s)
- 2013 American Health, Inc.
- Royal Brittany EPO is one of the best products of its kind on the market.
- Royal Brittany EPO assures quality, reliability, and purity.

Brand Information

See all products by this brand

Carefully Manufactured by
Name American Health, Inc.
City Ronkonkoma
State NY
Country U.S.A.
ZipCode 11779
Phone Number 800-445-7137
Web Address www.AmericanHealthUS.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.